Hong Kong stocks' innovative drug sector continued to strengthen in the afternoon, with Innovent Biologics rising by more than 10%

2025-04-22 13:35:51

The Hong Kong stock market's innovative drug sector continued to strengthen in the afternoon, with Innovent Biologics and Innovent Biologics rising by more than 10%, BeiGene rising by nearly 10%, and CSPC Pharmaceutical Group, Rongchang Biopharma, and WuXi Biologics all rising sharply.

BeiGene WuXi Biologics

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Amazon will soon begin directly sourcing a wider variety of Nike products to expand selection for customers in the United States.
                            2025-05-22

                                    U.S. stocks closed, Dow fell 0.27%
                            2025-05-21

                                    Red Hat announces Red Hat AI Inference Server
                            2025-05-21

                                    Zheng Zhajie, Director of the National Development and Reform Commission, meets with Luhut, Chairman of the Indonesian National Economic Council
                            2025-05-21

                                    China Electronics Port stated on an interactive platform on May 22 that the company's current business cooperation with Xiaomi is mainly in mobile phones, home appliances, televisions, automobiles, ecological chains, etc., and there is no business cooperation in self-developed chips.
                            2025-05-22